LIVE
Anthem Biosciences Limited operates as a contract research, development, and manufacturing organization in India, rest of Asia, North America, Europe, and internationally. It operates in two segments: Contract Manufacturing, Development & Discovery Services; and Speciality Ingredients. The company offers contract research development and manufacturing services, such as end-to-end services across the new chemical entity and new biological entity lifecycles, as well as engages in contract research, development, and manufacturing of development batches of molecules used for clinical trials up to. Track ANTHEM BIOSCIENCES LTD's live NSE:ANTHEM share price ₹805.50 (-0.56%), market cap ₹₹452B, P/E 79.6. MarketRipple's AI analysis covers the investment thesis, ripple-chain impact, and Healthcare sector outlook for ANTHEM — real-time NSE India stock intelligence.
Open
₹819.00
High
₹819.00
Low
₹804.10
Prev. Close
₹810.00
52W High
₹873.50
52W Low
₹579.15
Anthem Biosciences Limited operates as a contract research, development, and manufacturing organization in India, rest of Asia, North America, Europe, and internationally. It operates in two segments: Contract Manufacturing, Development & Discovery Services; and Speciality Ingredients. The company offers contract research development and manufacturing services, such as end-to-end services across the new chemical entity and new biological entity lifecycles, as well as engages in contract research, development, and manufacturing of development batches of molecules used for clinical trials up to
Key Takeaway
ANTHEM BIOSCIENCES LTD is rated strong buy with a P/E of 79.6x — understand the valuation context before sizing a position.
★ Recommended
Ask AI: Is ANTHEM BIOSCIENCES LTD fairly valued right now?
Because a P/E of 79.6x needs to be compared against sector peers and growth expectations to be meaningful.
Continue Research
View events affecting ANTHEM BIOSCIENCES LTD
Because the investment case must account for macro and company-specific developments — events reveal the 'why' behind price moves.
Trace sector ripple effects
Because Healthcare moves create upstream and downstream implications that affect the entire thesis.
Intelligence Path
Growth
Govt Exposure
Policy Dependence
Execution Quality
News Sensitivity
Debt Strength
418 Cr
Revenue
120 Cr
Net Profit
0%
ROE
0%
ROCE
10.12
EPS
| ₹ in Crore | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|
| Revenue | 1,057 | 1,419 | 1,845 | 2,124 | 2,002 |
| Net Profit | 385 | 367 | 451 | 592 | 576 |
| ROE (%) | — | — | — | 0.0% | 0.0% |
| EPS (₹) | — | — | — | 10.12 | 10.12 |
| Debt/Equity | — | — | — | 1.8 | 1.8 |